Overview

Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris

Status:
Completed

Trial end date:
2013-12-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to compare the safety and efficacy profiles of Taro Pharmaceutical Inc.'s Clindamycin Phosphate and Benzoyl Peroxide Gel 1.2%/2.5% to Acanya® (Clindamycin Phosphate and Benzoyl Peroxide) Gel, 1.2%/2.5% and to demonstrate the superior efficacy of the two active formulations over that of the vehicle in the treatment of acne vulgaris.

Phase:

Phase 1

Details

Lead Sponsor:

Taro Pharmaceuticals USA

Treatments:

Benzoyl Peroxide
Clindamycin
Clindamycin palmitate
Clindamycin phosphate